Chemical Component Summary

Nametrans-4-({9-[(3S)-tetrahydrofuran-3-yl]-8-[(2,4,6-trifluorophenyl)amino]-9H-purin-2-yl}amino)cyclohexanol
Identifiers4-[[9-[(3S)-oxolan-3-yl]-8-[[2,4,6-tris(fluoranyl)phenyl]amino]purin-2-yl]amino]cyclohexan-1-ol
FormulaC21 H23 F3 N6 O2
Molecular Weight448.442
TypeNON-POLYMER
Isomeric SMILESc1c(cc(c(c1F)Nc2nc3cnc(nc3n2[C@H]4CCOC4)NC5CCC(CC5)O)F)F
InChIInChI=1S/C21H23F3N6O2/c22-11-7-15(23)18(16(24)8-11)28-21-27-17-9-25-20(26-12-1-3-14(31)4-2-12)29-19(17)30(21)13-5-6-32-10-13/h7-9,12-14,31H,1-6,10H2,(H,27,28)(H,25,26,29)/t12-,13-,14-/m0/s1
InChIKeyIBGLGMOPHJQDJB-IHRRRGAJSA-N

Chemical Details

Formal Charge0
Atom Count55
Chiral Atom Count1
Bond Count59
Aromatic Bond Count16

Drug Info: DrugBank

DrugBank IDDB11798 
NameTanzisertib
Groups investigational
DescriptionTanzisertib has been used in trials studying the treatment of Fibrosis, Discoid Lupus, Pulmonary Fibrosis, Interstitial Lung Disease, and Lung Diseases, Interstitial, among others.
Synonyms
  • TRANS-4-((9-((3S)-TETRAHYDROFURAN-3-YL)-8-((2,4,6-TRIFLUOROPHENYL)AMINO)-9H-PURIN-2- YL)AMINO)CYCLOHEXANOL
  • CYCLOHEXANOL, 4-((9-((3S)-TETRAHYDRO-3-FURANYL)-8-((2,4,6-TRIFLUOROPHENYL)AMINO)-9H-PURIN-2-YL)AMINO)-, TRANS-
  • 4-[[9-(3S)-tetrahydro-3-furanyl]-8-[(2,4,6-trifluorophenyl)amino]-9H-purin-2-yl]amino]-trans-cyclohexanol
  • Tanzisertib
Categories
  • Alcohols
  • Carbon Radioisotopes
  • Cyclohexanes
  • Cycloparaffins
  • Fatty Alcohols
CAS number899805-25-5